News & Events

Check out the latest news and events in the Wockhardt USA community.

21
Apr

Statement Regarding Promethazine with Codeine Cough Syrup

Posted on in News
  • Font size: Larger Smaller
  • Print

STATEMENT REGARDING PROMETHAZINE WITH CODEINE COUGH SYRUP

Parsippany, N.J., August, 21, 2015 - Recent news stories have highlighted a disturbing practice: the unapproved use of prescription cough medication in a homemade drug cocktail called “sizzurp” or “purple drank.” While some may attempt to glamorize it, prescription drug abuse is a public health problem.

When used properly, prescription promethazine with codeine cough syrup – manufactured by our company and other suppliers – may offer temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold to numerous patients who suffer from these ailments each year. However, the misuse of this drug may increase its risks, including those relating to respiratory depression and hypotension.

We will continue to work with law enforcement and others to deter the unauthorized use of prescription cough medicine.

About Wockhardt

Wockhardt USA LLC and Morton Grove Pharmaceuticals, Inc. are indirect subsidiaries of Wockhardt Limited, a global pharmaceutical and biotechnology organization, providing affordable high-quality medicines for a healthier world. Wockhardt Limited is India’s leading research-based global healthcare enterprise with relevance in the fields of pharmaceuticals, biotechnology and a chain of advanced specialty hospitals. Wockhardt has three research centers and twelve manufacturing plants, with businesses ranging from the manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (API) and vaccines.